Cardinal Health stock gains ahead of Thursday's earnings test

Company: Cardinal Health, Inc.
ISIN: US14149Y1082
NYSE ticker: CAH
Lang & Schwarz quote: 226.85 euros on November 3, 2026 at 3:34 p.m. CET
Next scheduled report: Fiscal first-quarter results on November 5, 2026

Published on 11/03/2026 at 15:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cardinal Health stock is heading into its fiscal first-quarter report on Thursday. The company has set the release for before the U.S. market opens.

Cardinal Health prepares for earnings

Fiscal first-quarter results are scheduled before the U.S. market opens on Thursday, November 5.
The release will provide the next test of Cardinal Health's fiscal 2027 outlook.
Investors are watching pharmaceutical distribution demand and specialty operations.

Cardinal Health, US14149Y1082, Illustration mit AI erstellt.

Cardinal Health is approaching its fiscal first-quarter earnings release with the shares above the level cited in the latest report. The company is scheduled to publish results before the U.S. market opens on Thursday, November 5, according to the Cardinal Health Newsroom.

The next earnings test

Cardinal Health's fiscal first-quarter release will give investors the next read-through on demand across its pharmaceutical distribution and specialty businesses. Management's fiscal 2027 outlook will also be measured against the quarter's results and commentary.

Cardinal Health stock traded at 226.85 euros on Lang & Schwarz at 3:34 p.m. CET on Tuesday, November 3, 2026. That was 1.50% above the 223.50-euro quote cited in the previous report from Monday, November 2, at 3:39 p.m. CET. This comparison is separate from the daily Xetra close.

The real-time quote of Cardinal Health stock gives investors a current reference point ahead of the results.